Evidence map›Paper›PMID 28275168›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.

Chad Tang, Steven I Sherman, Mellanie Price, Jun Weng, Suzanne E Davis, David S Hong, James C Yao, Aman Buzdar, George Wilding, J Jack Lee

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Uncovering key clinical trial features influencing recruitment.Journal of clinical and translational science · 2023
    Article
  12. Principal Investigators' Perceptions on Factors Associated with Successful Recruitment in Clinical Trials.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chad TangDepartment of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas. jjlee@mdanderson.org ctang1@mdanderson.org.
Steven I ShermanDepartment of Endocrine Neoplasia and Hormonal Disorders, MD Anderson Cancer Center, Houston, Texas.
Mellanie PriceOffice of Vice Provost for Clinical and Interdisciplinary Research, MD Anderson Cancer Center, Houston, Texas.
Jun WengDepartment of Biostatistics, MD Anderson Cancer Center, Houston, Texas.
Suzanne E DavisOffice of Vice Provost for Clinical and Interdisciplinary Research, MD Anderson Cancer Center, Houston, Texas.
David S HongDepartment of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas.
James C YaoDepartment of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
Aman BuzdarDepartment of Breast Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
George WildingOffice of Vice Provost for Clinical and Interdisciplinary Research, MD Anderson Cancer Center, Houston, Texas.
J Jack LeeDepartment of Biostatistics, MD Anderson Cancer Center, Houston, Texas. jjlee@mdanderson.org ctang1@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicHumansNational Cancer Institute (U.S.)NeoplasmsPatient SelectionResearch DesignUnited States

Identifiers

PMID28275168
PMCPMC5354950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.